Tyzeka Oral Tablet 600Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Tyzeka: Oral tablet (600mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_11257.JPG
Tyzeka 600mg Tab
Novartis Pharmaceuticals Corp
Pill Identification: LDT 

What is this Medicine?

TELBIVUDINE (tel BIV ue deen) is an antiviral medicine. It is used to treat hepatitis. This medicine will not cure hepatitis. It will not stop the spread of hepatitis to others.

In-Depth Information
Select a Medication

Tyzeka 600mg Tablet

NDC: 000780538
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hepatitis B Infection

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Tyzeka 600mg Tablet
Drug Image file DrugItem_11257.JPG
Novartis Pharmaceuticals Corp
Pill Identification: LDT 
Shape: oval
Color: white

Reported Side Effects for Tyzeka 600mg Tablet

Nerve Pain Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Disease Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
2.0%*
Severity: MILD
Onset: RAPID
Liver Infection Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
3.0-7.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
3.0-6.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
4.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Resistance To Antibiotics Incidence:
7.0-22.0%*
Severity: MODERATE
Onset: DELAYED
Headache Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
13.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Tyzeka 600mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Tyzeka 600mg Tablet(Telbivudine)
Marijuana and Nucleoside reverse transcriptase inhibitors(Telbivudine)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral nucleoside reverse transcriptase inhibitors (NRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Tyzeka

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5